⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL1853443 | 0.98 | — | — | |
| SCHEMBL7689470 | 0.82 | HRH3 (0.30) | — | |
| SCHEMBL7155504 | 0.80 | SIGMAR1 (0.30) | — | |
| SCHEMBL9602722 | 0.80 | — | — | |
| SCHEMBL1590532 | 0.80 | SMN1; SMN2 (0.37) | — | |
| SCHEMBL4366121 | 0.79 | L3MBTL1 (0.33) | — | |
| SCHEMBL99125 | 0.70 | GAA (0.31) | — | |
| SCHEMBL99816 | 0.69 | KMT2A (0.33) | — | |
| SCHEMBL3700579 | 0.69 | CHRM2 (0.32) | — | |
| SCHEMBL2532935 | 0.67 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-7612075-B2 | Substituted oxoazaheterocyclyl compounds | AVENTIS PHARMACEUTICALS INC. (US) | 2009-11-03 | — | — | US | disclosed |
| US-20040102450-A1 | Substituted oxoazaheterocyclyl compounds | AVENTIS PHARMACEUTICALS INC. (US) | 2004-05-27 | — | — | US | disclosed |
| EP-1208097-A2 | SUBSTITUTED OXOAZAHETEROCYCLYL COMPOUNDS | Aventis Pharmaceuticals Inc. (US) | 2002-05-29 | — | — | EP | disclosed |
| WO-2001007436-A2 | SUBSTITUTED OXOAZAHETEROCYCLYL COMPOUNDS | AVENTIS PHARMACEUTICALS INC. (US) | 2001-02-01 | — | — | WO | disclosed |